Biopharma Processing Equipment Market to Hit $116.4 Billion by 2034 as Single-Use Adoption Accelerates
Updated
Updated · PR Newswire · Jul 7
Biopharma Processing Equipment Market to Hit $116.4 Billion by 2034 as Single-Use Adoption Accelerates
1 articles · Updated · PR Newswire · Jul 7
Summary
$116.4 billion is DelveInsight’s 2034 forecast for the global biopharmaceutical processing equipment and consumables market, up from $52.1 billion in 2025 at about 9% annual growth.
Rising biologics, biosimilars, vaccine, and cell-and-gene therapy output is driving demand for scalable, compliant manufacturing systems, while capacity expansion by drugmakers and CDMOs is lifting purchases of bioreactors, filtration and chromatography equipment.
Single-use technologies, automation, continuous bioprocessing and digital monitoring are gaining share because they cut contamination risk, reduce cleaning needs and improve turnaround times and flexibility.
North America held the largest regional share in 2025 at roughly 38% of revenue, with filtration systems the biggest product segment; Asia-Pacific was identified as a key growth hub as China, India, South Korea and Japan expand biologics capacity.
Recent investments underscore the buildout: Sartorius said in February 2026 it would invest about EUR 442 million in bioprocess capacity, while Cytiva expanded membrane output by 20% in Florida in 2025.
Is the biomanufacturing sector's growth too dependent on the success of GLP-1 obesity drugs?
Is biopharma's boom in single-use plastics creating a new environmental crisis?
As AI labs accelerate research, what is the future for human scientists in drug discovery?
Bioprocessing Market Set for 11.4% CAGR Through 2033: Single-Use Revolution, Regulatory Shifts, and Sustainability in Focus
Overview
The bioprocessing market is gaining strong momentum as of July 2026, fueled by substantial investments and a rapidly growing demand for biopharmaceuticals. This surge is driving both large and small-scale operations to expand, with a strategic focus on enhancing manufacturing capabilities and supporting innovative therapies. The industry is set for continued growth through 2034, as companies adopt advanced technologies and scale up production to meet increasing needs. These trends highlight a dynamic market environment where investment, demand, and innovation are closely linked, shaping the future of bioprocessing.